Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.

Markusse IM, Akdemir G, Dirven L, Goekoop-Ruiterman YP, van Groenendael JH, Han KH, Molenaar TH, Le Cessie S, Lems WF, van der Lubbe PA, Kerstens PJ, Peeters AJ, Ronday HK, de Sonnaville PB, Speyer I, Stijnen T, Ten Wolde S, Huizinga TW, Allaart CF.

Ann Intern Med. 2016 Apr 19;164(8):523-31. doi: 10.7326/M15-0919. Epub 2016 Mar 1.

PMID:
27089068
2.

Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis.

Bergstra SA, Markusse IM, Akdemir G, Ronday HK, Han KH, Lems WF, Kerstens PJSM, van den Berg R, Landewé RBM, Allaart CF.

Clin Rheumatol. 2016 Aug;35(8):2101-2107. doi: 10.1007/s10067-015-3145-1. Epub 2015 Dec 22.

3.

Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Markusse IM, Dirven L, Gerards AH, van Groenendael JH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2.

4.

Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.

Markusse IM, Dirven L, Han KH, Ronday HK, de Sonnaville PB, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):446-53. doi: 10.1002/acr.22681.

5.

Continued participation in a ten-year tight control treat-to-target study in rheumatoid arthritis: why keep patients doing their best?

Markusse IM, Dirven L, Han KH, Ronday HK, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Arthritis Care Res (Hoboken). 2015 May;67(6):739-45. doi: 10.1002/acr.22540.

6.

Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?

Heimans L, Wevers-deBoer KV, Ronday HK, Collée G, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Clin Rheumatol. 2015 Jan;34(1):163-6. doi: 10.1007/s10067-014-2815-8. Epub 2014 Nov 29.

PMID:
25431327
7.

A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.

Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

J Rheumatol. 2014 Nov;41(11):2114-9. doi: 10.3899/jrheum.131412. Epub 2014 Aug 15.

8.

The relationship between disease activity and depressive symptoms severity and optimism--results from the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Ronday HK, Steup-Beekman GM, van Oosterhout M, Huizinga TW, Giltay EJ, van der Mast RC, Allaart CF.

Clin Rheumatol. 2013 Dec;32(12):1751-7. doi: 10.1007/s10067-013-2337-9. Epub 2013 Jul 24.

PMID:
23881438
9.

Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.

van den Broek M, Dirven L, Kroon HM, Kloppenburg M, Ronday HK, Peeters AJ, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

J Rheumatol. 2013 May;40(5):624-9. doi: 10.3899/jrheum.121248. Epub 2013 Apr 1.

PMID:
23547212
10.

Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).

van Aken J, Heimans L, Gillet-van Dongen H, Visser K, Ronday HK, Speyer I, Peeters AJ, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Feb;73(2):396-400. doi: 10.1136/annrheumdis-2012-202967. Epub 2013 Jan 19.

PMID:
23334213
11.

'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'.

Koevoets R, Dirven L, Klarenbeek NB, van Krugten MV, Ronday HK, van der Heijde DM, Huizinga TW, Kerstens PS, Lems WF, Allaart CF.

Ann Rheum Dis. 2013 Jun;72(6):870-4. doi: 10.1136/annrheumdis-2011-201191. Epub 2012 Jun 30.

PMID:
22753403
12.

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).

Wevers-de Boer K, Visser K, Heimans L, Ronday HK, Molenaar E, Groenendael JH, Peeters AJ, Westedt ML, Collée G, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2012 Sep;71(9):1472-7. doi: 10.1136/annrheumdis-2011-200736. Epub 2012 Mar 8.

PMID:
22402145
13.

Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies.

van der Woude D, Visser K, Klarenbeek NB, Ronday HK, Peeters AJ, Kerstens PJ, Dijkmans BA, Huizinga TW, van der Helm-van Mil AH, Allaart CF.

Rheumatology (Oxford). 2012 Jun;51(6):1120-8. doi: 10.1093/rheumatology/ker516. Epub 2012 Feb 15.

PMID:
22337939
14.

Promoting physical activity in patients with rheumatoid arthritis: rheumatologists' and health professionals' practice and educational needs.

Hurkmans EJ, de Gucht V, Maes S, Peeters AJ, Ronday HK, Vliet Vlieland TP.

Clin Rheumatol. 2011 Dec;30(12):1603-9. doi: 10.1007/s10067-011-1846-7. Epub 2011 Sep 13.

15.

Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial.

Dirven L, Güler-Yüksel M, de Beus WM, Ronday HK, Speyer I, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1691-9. doi: 10.1002/acr.20612.

16.

Effect of self-efficacy and physical activity goal achievement on arthritis pain and quality of life in patients with rheumatoid arthritis.

Knittle KP, De Gucht V, Hurkmans EJ, Vlieland TP, Peeters AJ, Ronday HK, Maes S.

Arthritis Care Res (Hoboken). 2011 Nov;63(11):1613-9. doi: 10.1002/acr.20587.

17.

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.

Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, Seys PE, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.

PMID:
21415052
18.

Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation study.

van der Giesen FJ, van Lankveld W, Hopman-Rock M, de Jong Z, Munneke M, Hazes JM, van Riel PL, Peeters AJ, Ronday HK, Vlieland TP.

Arthritis Care Res (Hoboken). 2010 Jun;62(6):865-72. doi: 10.1002/acr.20138.

19.

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.

Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2010 Jul;69(7):1333-7. doi: 10.1136/ard.2009.121160. Epub 2010 May 24.

PMID:
20498212
20.

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis.

Güler-Yüksel M, Klarenbeek NB, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van der Kooij SM, Gerards AH, Ronday HK, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF.

Arthritis Res Ther. 2010;12(3):R96. doi: 10.1186/ar3025. Epub 2010 May 20.

21.

Motivation as a determinant of physical activity in patients with rheumatoid arthritis.

Hurkmans EJ, Maes S, de Gucht V, Knittle K, Peeters AJ, Ronday HK, Vlieland TP.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):371-7. doi: 10.1002/acr.20106.

22.

Acute transverse myelitis in psoriatic arthritis.

Rath JJ, Ronday HK, Wirtz PW.

J Neurol. 2010 Mar;257(3):457-8. doi: 10.1007/s00415-009-5361-6. Epub 2009 Dec 10. No abstract available.

PMID:
20012314
23.

Cutaneous gamma/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis.

Koens L, Senff NJ, Vermeer MH, Ronday HK, Willemze R, Jansen PM.

Acta Derm Venereol. 2009 Nov;89(6):653-4. doi: 10.2340/00015555-0728. No abstract available.

24.

Assistive devices: usage in patients with rheumatoid arthritis.

de Boer IG, Peeters AJ, Ronday HK, Mertens BJ, Huizinga TW, Vliet Vlieland TP.

Clin Rheumatol. 2009 Feb;28(2):119-28. doi: 10.1007/s10067-008-0989-7. Epub 2008 Aug 26.

PMID:
18726549
25.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
26.

Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

Arthritis Rheum. 2008 May;58(5):1293-8. doi: 10.1002/art.23439.

27.

Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT study.

de Jong Z, Munneke M, Vilim V, Zwinderman AH, Kroon HM, Ronday HK, Lems WF, Dijkmans BA, Breedveld FC, Vliet Vlieland TP, Hazes JM, Degroot J.

Rheumatology (Oxford). 2008 Jun;47(6):868-71. doi: 10.1093/rheumatology/ken052. Epub 2008 Apr 9.

PMID:
18400837
28.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2008 Feb;58(2 Suppl):S126-35. doi: 10.1002/art.23364.

29.

RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro.

Steenvoorden MM, Toes RE, Ronday HK, Huizinga TW, Degroot J.

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):740-2.

PMID:
18078623
30.

The usage of functional wrist orthoses in patients with rheumatoid arthritis.

de Boer IG, Peeters AJ, Ronday HK, Mertens BJ, Breedveld FC, Vliet Vlieland TP.

Disabil Rehabil. 2008;30(4):286-95.

PMID:
17852215
31.

Fibroblast-like synoviocyte-chondrocyte interaction in cartilage degradation.

Steenvoorden MM, Bank RA, Ronday HK, Toes RE, Huizinga TW, DeGroot J.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):239-45.

PMID:
17543148
32.

Sick leave and work disability in patients with early arthritis.

Zirkzee EJ, Sneep AC, de Buck PD, Allaart CF, Peeters AJ, Ronday HK, Westedt ML, le Cessie S, Vliet Vlieland TP.

Clin Rheumatol. 2008 Jan;27(1):11-9. Epub 2007 May 10.

33.

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.

van Dongen H, van Aken J, Lard LR, Visser K, Ronday HK, Hulsmans HM, Speyer I, Westedt ML, Peeters AJ, Allaart CF, Toes RE, Breedveld FC, Huizinga TW.

Arthritis Rheum. 2007 May;56(5):1424-32.

34.

Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis.

Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Peeters AJ, de Jonge-Bok JM, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.

Ann Rheum Dis. 2007 Nov;66(11):1508-12. Epub 2007 Apr 24.

35.

Using internet technology to deliver a home-based physical activity intervention for patients with rheumatoid arthritis: A randomized controlled trial.

van den Berg MH, Ronday HK, Peeters AJ, le Cessie S, van der Giesen FJ, Breedveld FC, Vliet Vlieland TP.

Arthritis Rheum. 2006 Dec 15;55(6):935-45.

36.

Engagement and satisfaction with an Internet-based physical activity intervention in patients with rheumatoid arthritis.

van den Berg MH, Ronday HK, Peeters AJ, Voogt-van der Harst EM, Munneke M, Breedveld FC, Vliet Vlieland TP.

Rheumatology (Oxford). 2007 Mar;46(3):545-52. Epub 2006 Oct 13.

PMID:
17043050
37.

Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes.

Steenvoorden MM, Huizinga TW, Verzijl N, Bank RA, Ronday HK, Luning HA, Lafeber FP, Toes RE, DeGroot J.

Arthritis Rheum. 2006 Jan;54(1):253-63.

38.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2005 Nov;52(11):3381-90.

39.

A comparison of the OARSI response criteria with patient's global assessment in patients with osteoarthritis of the hip treated with a non-pharmacological intervention.

Hoeksma HL, van den Ende CH, Breedveld FC, Ronday HK, Dekker J.

Osteoarthritis Cartilage. 2006 Jan;14(1):77-81. Epub 2005 Oct 7.

40.

Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss.

de Buck PD, le Cessie S, van den Hout WB, Peeters AJ, Ronday HK, Westedt ML, Breedveld FC, Vliet Vlieland TP.

Arthritis Rheum. 2005 Oct 15;53(5):682-90.

41.

Effect of a high-intensity weight-bearing exercise program on radiologic damage progression of the large joints in subgroups of patients with rheumatoid arthritis.

Munneke M, de Jong Z, Zwinderman AH, Ronday HK, van Schaardenburg D, Dijkmans BA, Kroon HM, Vliet Vlieland TP, Hazes JM.

Arthritis Rheum. 2005 Jun 15;53(3):410-7.

42.

Manual therapy in osteoarthritis of the hip: outcome in subgroups of patients.

Hoeksma HL, Dekker J, Ronday HK, Breedveld FC, Van den Ende CH.

Rheumatology (Oxford). 2005 Apr;44(4):461-4. Epub 2005 Feb 3.

PMID:
15695307
43.

Comparison of manual therapy and exercise therapy in osteoarthritis of the hip: a randomized clinical trial.

Hoeksma HL, Dekker J, Ronday HK, Heering A, van der Lubbe N, Vel C, Breedveld FC, van den Ende CH.

Arthritis Rheum. 2004 Oct 15;51(5):722-9.

44.

MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.

Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM, Huizinga TW, DeGroot J, Hanemaaijer R.

Ann Rheum Dis. 2004 Jul;63(7):881-3.

45.

High intensity exercise or conventional exercise for patients with rheumatoid arthritis? Outcome expectations of patients, rheumatologists, and physiotherapists.

Munneke M, de Jong Z, Zwinderman AH, Ronday HK, van den Ende CH, Vliet Vlieland TP, Hazes JM.

Ann Rheum Dis. 2004 Jul;63(7):804-8.

46.

Adherence and satisfaction of rheumatoid arthritis patients with a long-term intensive dynamic exercise program (RAPIT program).

Munneke M, de Jong Z, Zwinderman AH, Jansen A, Ronday HK, Peter WF, Boonman DC, van den Ende CH, Vliet Vlieland TP, Hazes JM.

Arthritis Rheum. 2003 Oct 15;49(5):665-72.

47.

Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip.

Hoeksma HL, Van Den Ende CH, Ronday HK, Heering A, Breedveld FC.

Ann Rheum Dis. 2003 Oct;62(10):935-8.

48.

No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study.

van der Laan WH, Ronday HK, TeKoppele JM, Breedveld FC, Huizinga TW, Verheijen JH.

Clin Exp Rheumatol. 2003 May-Jun;21(3):359-62.

PMID:
12846058
49.

Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis.

Ronday HK, van der Laan WH, Tak PP, de Roos JA, Bank RA, TeKoppele JM, Froelich CJ, Hack CE, Hogendoorn PC, Breedveld FC, Verheijen JH.

Rheumatology (Oxford). 2001 Jan;40(1):55-61.

PMID:
11157142
50.

Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.

van der Laan WH, Pap T, Ronday HK, Grimbergen JM, Huisman LG, TeKoppele JM, Breedveld FC, Gay RE, Gay S, Huizinga TW, Verheijen JH, Quax PH.

Arthritis Rheum. 2000 Aug;43(8):1710-8.

Supplemental Content

Loading ...
Support Center